Fortrea Holdings (FTRE) Free Cash Flow (2022 - 2026)
Fortrea Holdings' (FTRE) quarterly Free Cash Flow came in at $19.9 million in Q2 2026, up 39.16% on a YoY basis from $14.3 million in Q2 2025, and up 179.6% quarter-over-quarter from -$25.0 million in Q1 2026.
Analysis
Fortrea Holdings (FTRE) Free Cash Flow (2022 - 2026) Analysis & Trends
Fortrea Holdings (FTRE) has reported Free Cash Flow for 5 consecutive years, with $19.9 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Free Cash Flow rose 39.16% year-over-year to $19.9 million; the trailing twelve-month figure through Jun 2026 stood at $196.0 million (up 290.11% YoY), and the FY2025 full-year result was $88.3 million, down 62.79% from the prior year.
- Free Cash Flow grew to $19.9 million in Q2 2026 per FTRE's latest filing, from -$25.0 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $262.5 million in Q2 2024 and bottomed at -$127.1 million in Q1 2025.
- Historically, Free Cash Flow has averaged $32.4 million across 5 years, with a median of $11.6 million in 2023.
- The widest YoY moves for Free Cash Flow: up 850.0% in 2025, down 264.18% in 2025.
- Over 5 years, Free Cash Flow stood at $5.1 million in 2022, then surged by 76.47% to $9.0 million in 2023, then soared by 125.56% to $20.3 million in 2024, then soared by 499.01% to $121.6 million in 2025, then tumbled by 83.63% to $19.9 million in 2026.
- According to Business Quant data, Free Cash Flow over the past three periods registered $19.9 million, -$25.0 million, and $121.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.29 Bn | 40.21 Bn | 1.44 Bn | 360.00 Mn |
| 2 | Medpace Holdings | 16.47 Bn | 15.97 Bn | 201.64 Mn | 138.10 Mn |
| 3 | Charles River Laboratories International | 13.17 Bn | 12.98 Bn | 452.07 Mn | 148.62 Mn |
| 4 | Icon | 12.39 Bn | 11.46 Bn | 479.29 Mn | 323.69 Mn |
| 5 | Fortrea Holdings | 1.57 Bn | 1.40 Bn | 139.20 Mn | 19.90 Mn |
| 6 | Evotec SE | 621.88 Mn | 196.00 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 419.76 Mn | 335.22 Mn | 18.44 Mn | -46.89 Mn |
| 8 | Champions Oncology | 71.65 Mn | 71.65 Mn | 7.03 Mn | -2.24 Mn |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn | -1.75 Mn |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - | -3.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19.90 Mn |
| Mar 31, 2026 | -25.00 Mn |
| Dec 31, 2025 | 121.60 Mn |
| Sep 30, 2025 | 79.50 Mn |
| Jun 30, 2025 | 14.30 Mn |
| Mar 31, 2025 | -127.10 Mn |
| Dec 31, 2024 | 20.30 Mn |
| Sep 30, 2024 | -10.60 Mn |
| Jun 30, 2024 | 262.50 Mn |
| Mar 31, 2024 | -34.90 Mn |
| Dec 31, 2023 | 9.00 Mn |
| Sep 30, 2023 | -3.20 Mn |
| Jun 30, 2023 | 140.50 Mn |
| Mar 31, 2023 | -18.20 Mn |
| Dec 31, 2022 | 5.10 Mn |
| Sep 30, 2022 | 63.90 Mn |